Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-11 | "Dr. Gowen was Senior Vice President for the Center of Excellence for External Drug Discovery at GlaxoSmithKline... She received her Ph.D.... an M.B.A.... and a B.Sc. with Honors in Biochemistry" |
| 2015-04-03 | Dr. Gowen has served as our President and Chief Executive Officer... She received her Ph.D. ... an M.B.A. ... and a B.Sc. with Honors in Biochemistry. |
| 2016-04-01 | "Dr. Gowen... received her Ph.D. from the University of Sheffield, U.K., an M.B.A. with academic honors from The Wharton School... and a B.Sc. with Honors in Biochemistry from the University of Bristol, U.K." |
| 2017-04-03 | "Dr. Gowen graduated with a B.Sc. in biochemistry... received a Ph.D. in cell biology... and received an MBA..." |
| 2018-04-02 | Dr. Gowen graduated with a B.Sc. in biochemistry ... received a Ph.D. in cell biology ... and received an MBA ... |
| 2019-04-02 | "Dr. Gowen graduated with a B.Sc. in biochemistry... then received a Ph.D. in cell biology..." |
| 2020-04-13 | "Dr. Gowen... held a variety of leadership roles... responsible for drug discovery and early development... She has authored more than 100 refereed scientific publications... received a Ph.D. in cell biology..." |
| 2021-04-09 | "Maxine Gowen, Ph.D." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04